UKTI will run a trade mission to Japan focussed on Life Sciences, date: 13-17 Feb 2012. At this mission, UK Biotech & Pharma and Healthcare & Medical companies have an opportunity to access key decision-makers and find future business partners within this lucrative market.
Why Japan?
- Japan is the world’s 2nd largest pharmaceutical market in the world worth £65bn. At 11% of the global market, it is bigger than France and Germany combined.
Japanese Biotech & Pharma companies have been proactively looking for R&D and in-licensing partners who can offer them promising drug candidates, novel DDS, formulations and also biomarkers. Opportunities also exist in services that enable pharmaceutical companies to reduce drug development times.
- Japan is also the world’s 2nd largest healthcare market, where the market for imports of medical devices alone is worth around £8bn.
Japanese Health & Medtech companies are urgently looking to acquire new research and product development pipelines from overseas. The Japanese government has reduced drug/device approval times. With the highest proportion of elderly people in the world, it is a long-term growth market. To seize the market opportunity, even huge Japanese electric and electronics corporations are diversifying into healthcare.
The Mission will give UK companies direct access to key contacts and future business partners in the Japanese companies that would take years to build in Japan otherwise. We will contact 1500 leading Japanese opinion formers in advance of your visit to showcase your company.
At the seminars in Tokyo and Osaka, companies will have an opportunity to present them to 100 decision makers from Japanese Biotech & Pharmaceuticals industry and Healthcare & Medtech industry, and then network with companies’ strategic partners and distributors. Past Japanese audience include world-leading companies such as Takeda, Eisai, Astellas, Daiichi-Sankyo, Mitsubishi Tanabe, Otsuka, Shionogi, Kyowa Hakko Kirin for biotech/pharma and Olympus, Terumo, Hitachi, Nihon Kohden, Sysmex, Panasonic Healthcare for healthcare/medical, as well as many other smaller innovative firms looking for ties ups with UK firms.
Please send applications to the UKTI Sectors Group by 30 Nov using the attached application form. Mission participation (ie seminars / networking receptions in Tokyo and Osaka) will involve £1,110.
In addition to the mission events, companies will get free access to “Nano Tech 2012” (www.nanotechexpo.jp/en/index.html), and to our colleagues from British Embassies in South Korea and Taiwan for advice about expansion into regional markets too.
Japan_Life%20Sciences_Mission_Application_Form.doc
UKTI_Japan_mission_flyer.pdf
You need to be a member of Life Sciences Scotland to add comments!
Join Life Sciences Scotland